choline has been researched along with Cardiovascular Diseases in 80 studies
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (8.75) | 18.7374 |
1990's | 1 (1.25) | 18.2507 |
2000's | 9 (11.25) | 29.6817 |
2010's | 35 (43.75) | 24.3611 |
2020's | 28 (35.00) | 2.80 |
Authors | Studies |
---|---|
Kang, JW | 1 |
Zivkovic, AM | 1 |
Golzarand, M | 1 |
Mirmiran, P | 1 |
Azizi, F | 1 |
Amrein, M | 1 |
Li, XS | 2 |
Walter, J | 1 |
Wang, Z | 7 |
Zimmermann, T | 1 |
Strebel, I | 1 |
Honegger, U | 1 |
Leu, K | 1 |
Schäfer, I | 1 |
Twerenbold, R | 1 |
Puelacher, C | 1 |
Glarner, N | 1 |
Nestelberger, T | 1 |
Koechlin, L | 1 |
Ceresa, B | 1 |
Haaf, P | 1 |
Bakula, A | 1 |
Zellweger, M | 1 |
Hazen, SL | 8 |
Mueller, C | 1 |
Cantero, MA | 1 |
Guedes, MRA | 1 |
Fernandes, R | 1 |
Lollo, PCB | 1 |
Fretts, AM | 1 |
Jensen, P | 1 |
Budoff, M | 1 |
Sitlani, CM | 1 |
Wang, M | 2 |
de Oliveira Otto, MC | 1 |
DiDonato, JA | 3 |
Lee, Y | 1 |
Psaty, BM | 1 |
Siscovick, DS | 1 |
Sotoodehnia, N | 1 |
Tang, WHW | 2 |
Lai, H | 1 |
Lemaitre, RN | 1 |
Mozaffarian, D | 1 |
Díez-Ricote, L | 2 |
San-Cristobal, R | 1 |
Concejo, MJ | 1 |
Martínez-González, MÁ | 2 |
Corella, D | 2 |
Salas-Salvadó, J | 2 |
Goday, A | 1 |
Martínez, JA | 1 |
Alonso-Gómez, ÁM | 1 |
Wärnberg, J | 1 |
Vioque, J | 1 |
Romaguera, D | 1 |
López-Miranda, J | 1 |
Estruch, R | 2 |
Tinahones, FJ | 1 |
Lapetra, J | 2 |
Serra-Majem, L | 2 |
Bueno-Cavanillas, A | 1 |
Tur, JA | 1 |
Martín Sánchez, V | 1 |
Pintó, X | 1 |
Gaforio, JJ | 1 |
Matía-Martín, P | 1 |
Vidal, J | 1 |
Mas Fontao, S | 1 |
Ros, E | 2 |
Vázquez-Ruiz, Z | 1 |
Ortega-Azorín, C | 1 |
García-Gavilán, JF | 1 |
Malcampo, M | 1 |
Martínez-Urbistondo, D | 1 |
Tojal-Sierra, L | 1 |
García Rodríguez, A | 1 |
Gómez-Bellvert, N | 1 |
Chaplin, A | 1 |
García-Ríos, A | 1 |
Bernal-López, RM | 1 |
Santos-Lozano, JM | 1 |
Basterra-Gortari, J | 1 |
Sorlí, JV | 1 |
Murphy, M | 1 |
Gasulla, G | 1 |
Micó, V | 2 |
Salaverria-Lete, I | 1 |
Goñi Ochandorena, E | 1 |
Babio, N | 1 |
Herraiz, X | 1 |
Ordovás, JM | 2 |
Daimiel, L | 2 |
Ruiz-Valderrey, P | 1 |
Blanco, R | 1 |
Tomé-Carneiro, J | 1 |
Dávalos, A | 1 |
Tacconi, E | 1 |
Palma, G | 1 |
De Biase, D | 1 |
Luciano, A | 1 |
Barbieri, M | 1 |
de Nigris, F | 1 |
Bruzzese, F | 1 |
Zhen, J | 1 |
Zhou, Z | 2 |
He, M | 1 |
Han, HX | 1 |
Lv, EH | 1 |
Wen, PB | 1 |
Liu, X | 2 |
Wang, YT | 1 |
Cai, XC | 1 |
Tian, JQ | 1 |
Zhang, MY | 1 |
Xiao, L | 1 |
Kang, XX | 1 |
Mu, HN | 1 |
Zhao, XH | 1 |
Zhang, RR | 1 |
Li, ZY | 2 |
Yang, RY | 1 |
Wang, SM | 1 |
Li, HX | 1 |
Chen, WX | 1 |
Dong, J | 1 |
Yang, Q | 2 |
Han, H | 1 |
Sun, Z | 1 |
Liu, L | 4 |
Zheng, X | 1 |
Meng, Z | 1 |
Tao, N | 1 |
Liu, J | 3 |
Eyupoglu, ND | 1 |
Caliskan Guzelce, E | 1 |
Acikgoz, A | 1 |
Uyanik, E | 1 |
Bjørndal, B | 1 |
Berge, RK | 3 |
Svardal, A | 2 |
Yildiz, BO | 1 |
Busnelli, M | 1 |
Manzini, S | 1 |
Chiesa, G | 1 |
Yang, JJ | 2 |
Lipworth, LP | 2 |
Shu, XO | 2 |
Blot, WJ | 1 |
Xiang, YB | 1 |
Steinwandel, MD | 1 |
Li, H | 3 |
Gao, YT | 1 |
Zheng, W | 2 |
Yu, D | 2 |
Fu, BC | 1 |
Hullar, MAJ | 1 |
Randolph, TW | 1 |
Franke, AA | 1 |
Monroe, KR | 1 |
Cheng, I | 1 |
Wilkens, LR | 1 |
Shepherd, JA | 1 |
Madeleine, MM | 1 |
Le Marchand, L | 1 |
Lim, U | 1 |
Lampe, JW | 1 |
Cappuccilli, M | 1 |
Bergamini, C | 1 |
Giacomelli, FA | 1 |
Cianciolo, G | 1 |
Donati, G | 1 |
Conte, D | 1 |
Natali, T | 1 |
La Manna, G | 1 |
Capelli, I | 1 |
Meyer, KA | 3 |
Ali, MA | 2 |
Nasir, M | 2 |
Pasha, TN | 2 |
Javid, I | 2 |
Ullah, A | 1 |
Iqbal, MA | 1 |
Ahmed, S | 2 |
Nazir, MM | 1 |
Gondal, TA | 2 |
Imran, M | 2 |
Sharifi-Rad, J | 2 |
Mahomoodally, MF | 1 |
Muzaffar, R | 1 |
Rashid, A | 1 |
Ur Rehman, H | 1 |
Iqbal, Z | 1 |
Cho, CE | 1 |
Aardema, NDJ | 1 |
Bunnell, ML | 1 |
Larson, DP | 1 |
Aguilar, SS | 1 |
Bergeson, JR | 1 |
Malysheva, OV | 2 |
Caudill, MA | 2 |
Lefevre, M | 1 |
Witkowski, M | 1 |
Weeks, TL | 1 |
Arias, N | 1 |
Arboleya, S | 1 |
Allison, J | 1 |
Kaliszewska, A | 1 |
Higarza, SG | 1 |
Gueimonde, M | 1 |
Arias, JL | 1 |
Nese, M | 1 |
Riboli, G | 1 |
Brighetti, G | 1 |
Sassi, V | 1 |
Camela, E | 1 |
Caselli, G | 1 |
Sassaroli, S | 1 |
Borlimi, R | 1 |
Aucoin, M | 1 |
Cooley, K | 1 |
Saunders, PR | 1 |
Carè, J | 1 |
Anheyer, D | 1 |
Medina, DN | 1 |
Cardozo, V | 1 |
Remy, D | 1 |
Hannan, N | 1 |
Garber, A | 1 |
Velayos, M | 1 |
Muñoz-Serrano, AJ | 1 |
Estefanía-Fernández, K | 1 |
Sarmiento Caldas, MC | 1 |
Moratilla Lapeña, L | 1 |
López-Santamaría, M | 1 |
López-Gutiérrez, JC | 1 |
Li, J | 2 |
Zhang, J | 2 |
Shen, S | 1 |
Zhang, B | 2 |
Yu, WW | 1 |
Toyoda, H | 1 |
Huang, DQ | 1 |
Le, MH | 1 |
Nguyen, MH | 1 |
Huang, R | 1 |
Zhu, L | 1 |
Wang, J | 6 |
Xue, L | 1 |
Yan, X | 2 |
Huang, S | 1 |
Li, Y | 7 |
Xu, T | 2 |
Li, C | 2 |
Ji, F | 1 |
Ming, F | 1 |
Zhao, Y | 2 |
Cheng, J | 1 |
Wang, Y | 3 |
Zhao, H | 1 |
Hong, S | 1 |
Chen, K | 2 |
Zhao, XA | 1 |
Zou, L | 1 |
Sang, D | 1 |
Shao, H | 1 |
Guan, X | 1 |
Chen, X | 2 |
Chen, Y | 5 |
Wei, J | 1 |
Zhu, C | 1 |
Wu, C | 1 |
Moore, HB | 1 |
Barrett, CD | 1 |
Moore, EE | 1 |
Jhunjhunwala, R | 1 |
McIntyre, RC | 1 |
Moore, PK | 1 |
Hajizadeh, N | 1 |
Talmor, DS | 1 |
Sauaia, A | 1 |
Yaffe, MB | 1 |
Liu, C | 3 |
Lin, Y | 1 |
Dong, Y | 1 |
Wu, Y | 5 |
Bao, Y | 1 |
Yan, H | 2 |
Ma, J | 1 |
Fernández-Cuadros, ME | 1 |
Albaladejo-Florín, MJ | 1 |
Álava-Rabasa, S | 1 |
Usandizaga-Elio, I | 1 |
Martinez-Quintanilla Jimenez, D | 1 |
Peña-Lora, D | 1 |
Neira-Borrajo, I | 1 |
López-Muñoz, MJ | 1 |
Rodríguez-de-Cía, J | 1 |
Pérez-Moro, OS | 1 |
Abdallah, M | 1 |
Alsaleh, H | 1 |
Baradwan, A | 1 |
Alfawares, R | 1 |
Alobaid, A | 1 |
Rasheed, A | 1 |
Soliman, I | 1 |
Wendel Garcia, PD | 1 |
Fumeaux, T | 1 |
Guerci, P | 1 |
Heuberger, DM | 1 |
Montomoli, J | 2 |
Roche-Campo, F | 1 |
Schuepbach, RA | 1 |
Hilty, MP | 1 |
Poloni, TE | 1 |
Carlos, AF | 1 |
Cairati, M | 1 |
Cutaia, C | 1 |
Medici, V | 1 |
Marelli, E | 1 |
Ferrari, D | 1 |
Galli, A | 1 |
Bognetti, P | 1 |
Davin, A | 1 |
Cirrincione, A | 1 |
Ceretti, A | 1 |
Cereda, C | 1 |
Ceroni, M | 1 |
Tronconi, L | 1 |
Vitali, S | 1 |
Guaita, A | 1 |
Leeds, JS | 1 |
Raviprakash, V | 1 |
Jacques, T | 1 |
Scanlon, N | 1 |
Cundall, J | 1 |
Leeds, CM | 1 |
Riva, A | 1 |
Gray, EH | 1 |
Azarian, S | 1 |
Zamalloa, A | 1 |
McPhail, MJW | 1 |
Vincent, RP | 1 |
Williams, R | 1 |
Chokshi, S | 1 |
Patel, VC | 1 |
Edwards, LA | 1 |
Alqarawi, W | 1 |
Birnie, DH | 1 |
Golian, M | 1 |
Nair, GM | 1 |
Nery, PB | 1 |
Klein, A | 1 |
Davis, DR | 1 |
Sadek, MM | 1 |
Neilipovitz, D | 1 |
Johnson, CB | 1 |
Green, MS | 1 |
Redpath, C | 1 |
Miller, DC | 1 |
Beamer, P | 1 |
Billheimer, D | 1 |
Subbian, V | 1 |
Sorooshian, A | 1 |
Campbell, BS | 1 |
Mosier, JM | 1 |
Novaretti, JV | 1 |
Astur, DC | 1 |
Cavalcante, ELB | 1 |
Kaleka, CC | 1 |
Amaro, JT | 1 |
Cohen, M | 1 |
Huang, W | 1 |
Li, T | 1 |
Ling, Y | 1 |
Qian, ZP | 1 |
Zhang, YY | 1 |
Huang, D | 1 |
Xu, SB | 1 |
Liu, XH | 1 |
Xia, L | 1 |
Yang, Y | 3 |
Lu, SH | 1 |
Lu, HZ | 1 |
Zhang, R | 2 |
Ma, JX | 1 |
Tang, S | 1 |
Li, CM | 1 |
Wan, J | 1 |
Wang, JF | 1 |
Ma, JQ | 1 |
Luo, JJ | 1 |
Chen, HY | 2 |
Mi, SL | 1 |
Chen, SY | 1 |
Su, YG | 1 |
Ge, JB | 1 |
Milheiro, SA | 1 |
Gonçalves, J | 1 |
Lopes, RMRM | 1 |
Madureira, M | 1 |
Lobo, L | 1 |
Lopes, A | 1 |
Nogueira, F | 1 |
Fontinha, D | 1 |
Prudêncio, M | 1 |
M Piedade, MF | 1 |
Pinto, SN | 1 |
Florindo, PR | 1 |
Moreira, R | 1 |
Castillo-Lora, J | 1 |
Delley, MF | 1 |
Laga, SM | 1 |
Mayer, JM | 1 |
Sutjarit, N | 1 |
Thongon, N | 1 |
Weerachayaphorn, J | 1 |
Piyachaturawat, P | 1 |
Suksamrarn, A | 1 |
Suksen, K | 1 |
Papachristou, DJ | 1 |
Blair, HC | 1 |
Hu, Y | 1 |
Shen, P | 1 |
Zeng, N | 1 |
Wang, L | 3 |
Yan, D | 1 |
Cui, L | 1 |
Yang, K | 2 |
Zhai, C | 1 |
Yang, M | 1 |
Lao, X | 1 |
Sun, J | 1 |
Ma, N | 1 |
Wang, S | 1 |
Ye, W | 1 |
Guo, P | 1 |
Rahimi, S | 1 |
Singh, MP | 1 |
Gupta, J | 1 |
Nakanishi, I | 1 |
Ohkubo, K | 1 |
Shoji, Y | 1 |
Fujitaka, Y | 1 |
Shimoda, K | 1 |
Matsumoto, KI | 1 |
Fukuhara, K | 1 |
Hamada, H | 1 |
van der Boom, T | 1 |
Gruppen, EG | 1 |
Lefrandt, JD | 1 |
Connelly, MA | 1 |
Links, TP | 1 |
Dullaart, RPF | 1 |
Berry, JD | 1 |
Bedlack, R | 1 |
Mathews, D | 1 |
Agnese, W | 1 |
Apple, S | 1 |
Meloncelli, S | 1 |
Divizia, M | 1 |
Germani, G | 1 |
Adefegha, SA | 1 |
Bottari, NB | 1 |
Leal, DB | 1 |
de Andrade, CM | 1 |
Schetinger, MR | 1 |
Martínez-Velasco, A | 1 |
Perez-Ortiz, AC | 1 |
Antonio-Aguirre, B | 1 |
Martínez-Villaseñor, L | 1 |
Lira-Romero, E | 1 |
Palacio-Pastrana, C | 1 |
Zenteno, JC | 1 |
Ramirez, I | 1 |
Zepeda-Palacio, C | 1 |
Mendoza-Velásquez, C | 1 |
Camacho-Ordóñez, A | 1 |
Ortiz Bibriesca, DM | 1 |
Estrada-Mena, FJ | 1 |
Martin, BL | 1 |
Thompson, LC | 1 |
Kim, YH | 2 |
Snow, SJ | 1 |
Schladweiler, MC | 1 |
Phillips, P | 1 |
Harmon, M | 1 |
King, C | 1 |
Richards, J | 1 |
George, I | 1 |
Haykal-Coates, N | 1 |
Gilmour, MI | 1 |
Kodavanti, UP | 1 |
Hazari, MS | 1 |
Farraj, AK | 1 |
Shen, Z | 1 |
Zou, Y | 1 |
Gao, K | 1 |
Lazar, S | 1 |
Wurtzel, JGT | 1 |
Ma, P | 1 |
Goldfinger, LE | 1 |
Vukelic, M | 1 |
Laloo, A | 1 |
Kyttaris, VC | 1 |
Chen, R | 1 |
Chen, J | 2 |
Xun, J | 1 |
Hu, Z | 1 |
Huang, Q | 2 |
Steinhart, C | 1 |
Shen, Y | 1 |
Lu, H | 1 |
Mansuri, A | 1 |
Lokhande, K | 1 |
Kore, S | 1 |
Gaikwad, S | 1 |
Nawani, N | 1 |
Swamy, KV | 1 |
Junnarkar, M | 1 |
Pawar, S | 1 |
Shaheen, MY | 1 |
Basudan, AM | 1 |
Niazy, AA | 1 |
van den Beucken, JJJP | 1 |
Jansen, JA | 1 |
Alghamdi, HS | 1 |
Gao, Q | 2 |
Guo, X | 1 |
Cao, Y | 1 |
Jia, X | 1 |
Xu, S | 1 |
Lu, C | 2 |
Zhu, H | 3 |
Melku, M | 1 |
Abebe, G | 1 |
Teketel, A | 1 |
Asrie, F | 1 |
Yalew, A | 1 |
Biadgo, B | 1 |
Kassa, E | 1 |
Damtie, D | 1 |
Anlay, DZ | 1 |
Ahmed, MFE | 1 |
Ramadan, H | 1 |
Seinige, D | 1 |
Kehrenberg, C | 1 |
Abd El-Wahab, A | 1 |
Volkmann, N | 1 |
Kemper, N | 1 |
Schulz, J | 1 |
Hu, MY | 1 |
Wu, YN | 1 |
McEvoy, MP | 1 |
Wang, YF | 1 |
Cong, WL | 1 |
Liu, LP | 1 |
Li, XX | 1 |
Zhou, CL | 1 |
Chen, WM | 1 |
Wei, KL | 1 |
Tung, SY | 1 |
Shen, CH | 1 |
Chang, TS | 1 |
Yen, CW | 1 |
Hsieh, YY | 1 |
Chiu, WN | 1 |
Hu, JH | 1 |
Lu, SN | 1 |
Hung, CH | 1 |
Alakavuklar, MA | 1 |
Fuqua, C | 1 |
Luo, KL | 1 |
Underwood, RS | 1 |
Greenwald, I | 1 |
Elashiry, MM | 1 |
Elashiry, M | 1 |
Zeitoun, R | 1 |
Elsayed, R | 1 |
Tian, F | 1 |
Saber, SE | 1 |
Elashry, SH | 1 |
Tay, FR | 1 |
Cutler, CW | 1 |
O'Dowd, A | 1 |
Maciel, M | 1 |
Poole, ST | 1 |
Jobling, MG | 1 |
Rollenhagen, JE | 1 |
Woods, CM | 1 |
Sincock, SA | 1 |
McVeigh, AL | 1 |
Gregory, MJ | 1 |
Maves, RC | 1 |
Prouty, MG | 1 |
Holmes, RK | 1 |
Savarino, SJ | 1 |
Mor, MK | 1 |
Palevsky, PM | 1 |
Kaufman, JS | 1 |
Thiessen Philbrook, H | 1 |
Weisbord, SD | 1 |
Parikh, CR | 1 |
John, CM | 1 |
Phillips, NJ | 1 |
Jarvis, GA | 1 |
Zhu, Y | 1 |
Kilburn, S | 1 |
Kapoor, M | 1 |
Chaturvedi, S | 1 |
Shaw, KJ | 1 |
Chaturvedi, V | 1 |
Kong, X | 1 |
Zhang, T | 1 |
Xiao, H | 1 |
Feng, X | 1 |
Tu, H | 1 |
Feng, J | 1 |
Sabet, M | 1 |
Tarazi, Z | 1 |
Griffith, DC | 1 |
Nguyen, F | 1 |
Guan, P | 1 |
Guerrero, DT | 1 |
Kolla, V | 1 |
Naraparaju, K | 1 |
Perry, LM | 1 |
Soberman, D | 1 |
Pressly, BB | 1 |
Alferiev, IS | 1 |
Chorny, M | 1 |
Brodeur, GM | 1 |
Gao, X | 2 |
Cheng, YH | 1 |
Enten, GA | 1 |
DeSantis, AJ | 1 |
Gaponenko, V | 1 |
Majetschak, M | 1 |
Kim, DY | 1 |
Choi, MJ | 1 |
Ko, TK | 1 |
Lee, NH | 1 |
Kim, OH | 1 |
Cheon, HG | 1 |
Cai, H | 2 |
Yip, V | 1 |
Lee, MV | 1 |
Wong, S | 1 |
Saad, O | 1 |
Ma, S | 1 |
Ljumanovic, N | 1 |
Khojasteh, SC | 1 |
Kamath, AV | 1 |
Shen, BQ | 1 |
Cuypers, ML | 1 |
Chanteux, H | 1 |
Gillent, E | 1 |
Bonnaillie, P | 1 |
Saunders, K | 1 |
Beckers, C | 1 |
Delatour, C | 1 |
Dell'Aiera, S | 1 |
Ungell, AL | 1 |
Nicolaï, J | 1 |
Knapp, AK | 1 |
Chen, A | 1 |
Griffin-Nolan, RJ | 1 |
Baur, LE | 1 |
Carroll, CJW | 1 |
Gray, JE | 1 |
Hoffman, AM | 1 |
Li, X | 4 |
Post, AK | 1 |
Slette, IJ | 1 |
Collins, SL | 1 |
Luo, Y | 1 |
Smith, MD | 1 |
Temitayo, GI | 1 |
Olawande, B | 1 |
Emmanuel, YO | 1 |
Timothy, AT | 1 |
Kehinde, O | 1 |
Susan, LF | 1 |
Ezra, L | 1 |
Joseph, OO | 1 |
Lev, S | 1 |
Desmarini, D | 1 |
Liuwantara, D | 1 |
Sorrell, TC | 1 |
Hawthorne, WJ | 1 |
Djordjevic, JT | 1 |
Verso, MG | 1 |
Costantino, C | 1 |
Marrella, A | 1 |
Immordino, P | 1 |
Vitale, F | 1 |
Amodio, E | 1 |
Wang, YD | 1 |
Yao, WL | 1 |
Xin, ZM | 1 |
Han, TT | 1 |
Wang, ZG | 1 |
Chen, L | 1 |
Cai, C | 1 |
Zhang, Y | 5 |
Ba, D | 1 |
Wen, S | 1 |
Tian, Q | 1 |
Lv, W | 1 |
Cheng, G | 1 |
Li, N | 1 |
Yue, XY | 1 |
Chu, WJ | 1 |
Chen, Q | 1 |
Choi, ES | 1 |
Zhao, X | 3 |
Zhou, HD | 1 |
Sun, XF | 1 |
Sharma, S | 2 |
Chhoker, S | 1 |
Xie, C | 1 |
Ong, EWY | 1 |
Tan, ZK | 1 |
Evans, S | 1 |
Weinheimer, CJ | 1 |
Kovacs, A | 1 |
Williams, JW | 1 |
Randolph, GJ | 1 |
Jiang, W | 1 |
Barger, PM | 1 |
Mann, DL | 1 |
Huang, Y | 1 |
Kong, L | 1 |
Yu, X | 2 |
Feng, B | 1 |
Liu, D | 1 |
Zhao, B | 1 |
Mendes, GC | 1 |
Yuan, P | 1 |
Ge, D | 1 |
Wang, WM | 1 |
Fontes, EPB | 1 |
Li, P | 1 |
Shan, L | 1 |
He, P | 1 |
Katoh, T | 1 |
Sengoku, T | 1 |
Hirata, K | 1 |
Ogata, K | 1 |
Suga, H | 1 |
Shun, C | 1 |
Yong-Yi, J | 1 |
Mei-Li, C | 1 |
Shi-Li, L | 1 |
Jian-Bo, Z | 1 |
Dan-Li, W | 1 |
Zhi-Min, G | 1 |
Ibrahim, AM | 1 |
Zakhary, SY | 1 |
Amin, SAW | 1 |
Ugurlu, M | 1 |
Fornari, VJ | 1 |
Hartmann, MSM | 1 |
Vanni, JR | 1 |
Rodriguez, R | 1 |
Langaro, MC | 1 |
Pelepenko, LE | 1 |
Zaia, AA | 1 |
Nakanjako, D | 1 |
Zalwango, F | 1 |
Wairagala, P | 1 |
Luboga, F | 1 |
Andia Biraro, I | 1 |
Bukirwa, VD | 1 |
Mboowa, MG | 1 |
Cose, S | 1 |
Seeley, J | 1 |
Elliott, A | 1 |
Zhao, G | 1 |
Sun, P | 1 |
Hao, S | 1 |
Wang, X | 1 |
Qu, G | 1 |
Xing, Y | 1 |
Xu, X | 1 |
Maierhofer, M | 1 |
Rieger, V | 1 |
Mayr, T | 1 |
Liu, Y | 2 |
Zhang, Q | 1 |
Bigliardi, AP | 1 |
Fernandes, CLF | 1 |
Pinto, EA | 1 |
Dos Santos, M | 1 |
Garcia, EM | 1 |
Baisch, PRM | 1 |
Soares, MCF | 1 |
Muccillo-Baisch, AL | 1 |
da Silva Júnior, FMR | 1 |
Yu, W | 1 |
Ju, C | 1 |
Wang, K | 1 |
Zheng, Z | 1 |
Liu, H | 1 |
Gao, Y | 1 |
Martínez-Navarro, EM | 1 |
Cebrián-Tarancón, C | 1 |
Moratalla-López, N | 1 |
Lorenzo, C | 1 |
Alonso, GL | 1 |
Salinas, RM | 1 |
Bermúdez de Castro, JM | 1 |
Modesto-Mata, M | 1 |
Martín-Francés, L | 1 |
García-Campos, C | 1 |
Martínez de Pinillos, M | 1 |
Martinón-Torres, M | 1 |
Hasani, M | 1 |
Wu, F | 2 |
Warriner, K | 1 |
Kurz, M | 1 |
Gretzke, D | 1 |
Hörlein, R | 1 |
Turpault, S | 1 |
Atzrodt, J | 1 |
Derdau, V | 1 |
Yao, Y | 1 |
Ou, X | 1 |
Zhao, S | 1 |
Tian, B | 1 |
Jin, S | 1 |
Jiang, Z | 1 |
Liu, M | 2 |
Jiang, GD | 1 |
Mou, LH | 1 |
Chen, JJ | 1 |
He, SG | 1 |
Reale, E | 1 |
Fustinoni, S | 1 |
Mercadante, R | 1 |
Polledri, E | 1 |
Hopf, NB | 1 |
Grant, PC | 1 |
Levy, K | 1 |
Lattimer, TA | 1 |
Depner, RM | 1 |
Kerr, CW | 1 |
Sato, J | 1 |
Merenda, MEZ | 1 |
Uemoto, AT | 1 |
Dos Santos, MP | 1 |
Barion, MRL | 1 |
Carciofi, AC | 1 |
de Paula Dorigam, JC | 1 |
Ribeiro, LB | 1 |
Vasconcellos, RS | 1 |
Waller, SB | 1 |
Peter, CM | 1 |
Hoffmann, JF | 1 |
Cleff, MB | 1 |
Faria de, RO | 1 |
Zani, JL | 1 |
Martins, BA | 1 |
Sande, D | 1 |
Solares, MD | 1 |
Takahashi, JA | 1 |
Yang, S | 2 |
Jia, Y | 1 |
Yin, C | 1 |
Zhao, R | 1 |
Ojha, M | 1 |
Wu, B | 1 |
Deepa, M | 1 |
Mo, J | 1 |
Au, DW | 1 |
Wan, MT | 1 |
Shi, J | 1 |
Zhang, G | 1 |
Winkler, C | 1 |
Kong, RY | 1 |
Seemann, F | 1 |
Bianco, M | 1 |
Calvano, CD | 1 |
Ventura, G | 1 |
Bianco, G | 1 |
Losito, I | 1 |
Cataldi, TRI | 1 |
Angiolella, L | 1 |
Staudt, A | 1 |
Duarte, PF | 1 |
Amaral, BPD | 1 |
Peixoto Andrade, BCO | 1 |
Simas, NK | 1 |
Correa Ramos Leal, I | 1 |
Sangenito, LS | 1 |
Santos, ALSD | 1 |
de Oliveira, D | 1 |
Junges, A | 1 |
Cansian, RL | 1 |
Paroul, N | 1 |
Siu, J | 1 |
Klingler, L | 1 |
Hung, CT | 1 |
Jeong, SH | 1 |
Smith, S | 1 |
Tingle, MD | 1 |
Wagner Mackenzie, B | 1 |
Biswas, K | 1 |
Douglas, RG | 1 |
Oza, AM | 1 |
Lorusso, D | 1 |
Aghajanian, C | 1 |
Oaknin, A | 1 |
Dean, A | 1 |
Colombo, N | 1 |
Weberpals, JI | 1 |
Clamp, AR | 1 |
Scambia, G | 1 |
Leary, A | 1 |
Holloway, RW | 1 |
Gancedo, MA | 1 |
Fong, PC | 1 |
Goh, JC | 1 |
O'Malley, DM | 1 |
Armstrong, DK | 1 |
Banerjee, S | 1 |
García-Donas, J | 1 |
Swisher, EM | 1 |
Cella, D | 1 |
Meunier, J | 1 |
Goble, S | 1 |
Cameron, T | 1 |
Maloney, L | 1 |
Mörk, AC | 1 |
Bedel, J | 1 |
Ledermann, JA | 1 |
Coleman, RL | 1 |
Vlek, SL | 1 |
Burm, R | 1 |
Govers, TM | 1 |
Vleugels, MPH | 1 |
Tuynman, JB | 1 |
Mijatovic, V | 1 |
Leicht, AS | 1 |
Connor, J | 1 |
Conduit, N | 1 |
Vaquera, A | 1 |
Gómez, MA | 1 |
McKay, JA | 1 |
Church, AL | 1 |
Rubin, N | 1 |
Emory, TH | 1 |
Hoven, NF | 1 |
Kuehn-Hajder, JE | 1 |
Nelson, MT | 1 |
Ramanna, S | 1 |
Auerbach, EJ | 1 |
Moeller, S | 1 |
Bolan, PJ | 1 |
Fox, NP | 1 |
Leonard, M | 1 |
Sjerps, MJ | 1 |
Chang, EF | 1 |
Hyun, S | 1 |
Saejio, A | 1 |
Shanmugam, S | 1 |
Sun, M | 1 |
Bai, Z | 1 |
Jaque-Fernandez, F | 1 |
Beaulant, A | 1 |
Berthier, C | 1 |
Monteiro, L | 1 |
Allard, B | 1 |
Casas, M | 1 |
Rieusset, J | 1 |
Jacquemond, V | 1 |
Góngora-García, OR | 1 |
Aca-Aca, G | 1 |
Baz-Rodríguez, SA | 1 |
Monte, A | 1 |
Maganaris, C | 1 |
Baltzopoulos, V | 1 |
Zamparo, P | 1 |
Hou, Y | 1 |
Cai, L | 1 |
Tu, YJ | 1 |
Tan, B | 1 |
Jiang, L | 1 |
Wu, ZH | 1 |
Yu, HJ | 1 |
Li, XQ | 1 |
Yang, AD | 1 |
Titze, IR | 1 |
Palaparthi, A | 1 |
Mau, T | 1 |
González, MA | 1 |
Goiri, F | 1 |
Barandika, JF | 1 |
García-Pérez, AL | 1 |
Jatt, LP | 1 |
Gandhi, MM | 1 |
Guo, R | 1 |
Sukhija-Cohen, A | 1 |
Bhattacharya, D | 1 |
Tseng, CH | 1 |
Chew, KW | 1 |
Onwumere, J | 1 |
Pia Tek, J | 1 |
Budnyak, T | 1 |
Budnyk, S | 1 |
Karim, Z | 1 |
Thersleff, T | 1 |
Kuśtrowski, P | 1 |
Mathew, AP | 1 |
Slabon, A | 1 |
Guo, M | 1 |
Zhao, T | 1 |
Xing, Z | 1 |
Qiu, Y | 1 |
Pan, K | 1 |
Li, Z | 2 |
Zhou, W | 1 |
Ghassemi Tabrizi, S | 1 |
Arbuznikov, AV | 1 |
Jiménez-Hoyos, CA | 1 |
Kaupp, M | 1 |
Lin, MH | 2 |
Bulman, DM | 1 |
Remucal, CK | 1 |
Chaplin, BP | 1 |
Laguerre, A | 1 |
George, LA | 1 |
Gall, ET | 1 |
Emerson, MS | 1 |
Wang, H | 3 |
Maginn, EJ | 1 |
Margulis, CJ | 1 |
Feng, W | 1 |
Kang, X | 2 |
Yan, S | 1 |
Chao, M | 1 |
Mo, S | 1 |
Sun, W | 1 |
Lu, Y | 2 |
Chen, C | 1 |
Stevens, DM | 1 |
Adiseshaiah, P | 1 |
Dasa, SSK | 1 |
Potter, TM | 1 |
Skoczen, SL | 1 |
Snapp, KS | 1 |
Cedrone, E | 1 |
Patel, N | 1 |
Busman-Sahay, K | 1 |
Rosen, EP | 1 |
Sykes, C | 1 |
Cottrell, M | 1 |
Dobrovolskaia, MA | 1 |
Estes, JD | 1 |
Kashuba, ADM | 1 |
Stern, ST | 1 |
Özütemiz, C | 1 |
Neil, EC | 1 |
Tanwar, M | 1 |
Rubin, NT | 1 |
Ozturk, K | 1 |
Cayci, Z | 1 |
Duscha, BD | 1 |
Kraus, WE | 1 |
Jones, WS | 1 |
Robbins, JL | 1 |
Piner, LW | 1 |
Huffman, KM | 1 |
Allen, JD | 1 |
Annex, BH | 1 |
Mehmood, T | 1 |
Ahmad, I | 1 |
Bibi, S | 1 |
Mustafa, B | 1 |
Ali, I | 1 |
Dahal, RH | 1 |
Chaudhary, DK | 1 |
Kim, DU | 1 |
Kim, J | 1 |
Yeter, HH | 1 |
Gonul, I | 1 |
Guz, G | 1 |
Helvaci, O | 1 |
Korucu, B | 1 |
Akcay, OF | 1 |
Derici, U | 1 |
Arinsoy, T | 1 |
Neffati, R | 1 |
Judeinstein, P | 1 |
Rault, J | 1 |
Xu, Y | 1 |
Chai, X | 1 |
Ren, T | 1 |
Yu, S | 1 |
Fu, Q | 2 |
Ye, J | 1 |
Ge, X | 1 |
Song, J | 1 |
Yang, H | 2 |
El-Baba, TJ | 1 |
Lutomski, CA | 1 |
Kantsadi, AL | 1 |
Malla, TR | 1 |
John, T | 1 |
Mikhailov, V | 1 |
Bolla, JR | 1 |
Schofield, CJ | 1 |
Zitzmann, N | 1 |
Vakonakis, I | 1 |
Robinson, CV | 1 |
Langham, MC | 1 |
Caporale, AS | 1 |
Wehrli, FW | 1 |
Parry, S | 1 |
Schwartz, N | 1 |
den Boer, RB | 1 |
Jones, KI | 1 |
Ash, S | 1 |
van Boxel, GI | 1 |
Gillies, RS | 1 |
O'Donnell, T | 1 |
Ruurda, JP | 1 |
Sgromo, B | 1 |
Silva, MA | 1 |
Maynard, ND | 1 |
Sivieri, EM | 1 |
Eichenwald, EC | 1 |
Rub, D | 1 |
Abbasi, S | 1 |
Krahnert, I | 1 |
Bolze, A | 1 |
Gibon, Y | 1 |
Fernie, AR | 1 |
Huang, L | 1 |
Wan, Y | 1 |
Dang, Z | 1 |
Yang, P | 1 |
Wu, S | 2 |
Lin, CC | 1 |
Hsu, CT | 1 |
Liu, W | 2 |
Huang, SC | 1 |
Kortz, U | 1 |
Mougharbel, AS | 1 |
Chen, TY | 1 |
Hu, CW | 1 |
Lee, JF | 1 |
Wang, CC | 1 |
Liao, YF | 1 |
Li, LJ | 1 |
Li, L | 2 |
Peng, S | 1 |
Stimming, U | 1 |
Hebbar Kannur, K | 1 |
Yaqub, TB | 1 |
Pupier, C | 1 |
Héau, C | 1 |
Cavaleiro, A | 1 |
Yamamoto, S | 1 |
Ono, A | 1 |
Matsui, J | 1 |
Hoshino, N | 1 |
Akutagawa, T | 1 |
Miyashita, T | 1 |
Mitsuishi, M | 1 |
Patel, SM | 1 |
Smith, TG | 1 |
Morton, M | 1 |
Stiers, KM | 1 |
Seravalli, J | 1 |
Mayclin, SJ | 1 |
Edwards, TE | 1 |
Tanner, JJ | 1 |
Becker, DF | 1 |
Butcher, TW | 1 |
Yang, JL | 1 |
Hartwig, JF | 1 |
Yu, MF | 1 |
Xia, ZZ | 1 |
Yao, JC | 1 |
Feng, Z | 1 |
Li, DH | 1 |
Liu, T | 1 |
Cheng, GJ | 1 |
He, DL | 1 |
Li, XH | 1 |
Huurman, R | 1 |
Schinkel, AFL | 1 |
de Jong, PL | 1 |
van Slegtenhorst, MA | 1 |
Hirsch, A | 1 |
Michels, M | 1 |
Kataja, A | 1 |
Tarvasmäki, T | 1 |
Lassus, J | 1 |
Sionis, A | 1 |
Mebazaa, A | 1 |
Pulkki, K | 1 |
Banaszewski, M | 1 |
Carubelli, V | 1 |
Hongisto, M | 1 |
Jankowska, E | 1 |
Jurkko, R | 1 |
Jäntti, T | 1 |
Kasztura, M | 1 |
Parissis, J | 1 |
Sabell, T | 1 |
Silva-Cardoso, J | 1 |
Spinar, J | 1 |
Tolppanen, H | 1 |
Harjola, VP | 1 |
Carsetti, A | 1 |
Damiani, E | 1 |
Casarotta, E | 1 |
Scorcella, C | 1 |
Domizi, R | 1 |
Gasparri, F | 1 |
Gabbanelli, V | 1 |
Pantanetti, S | 1 |
Carozza, R | 1 |
Adrario, E | 1 |
Donati, A | 1 |
Almada, E | 1 |
Pariani, A | 1 |
Rivabella Maknis, T | 1 |
Hidalgo, F | 1 |
Vena, R | 1 |
Favre, C | 1 |
Larocca, MC | 1 |
Lu, ZY | 1 |
Jiang, WD | 1 |
Wu, P | 1 |
Kuang, SY | 1 |
Tang, L | 1 |
Yang, J | 1 |
Zhou, XQ | 1 |
Feng, L | 1 |
Leal, M | 1 |
Zampini, IC | 1 |
Mercado, MI | 1 |
Moreno, MA | 1 |
Simirgiotis, MJ | 1 |
Bórquez, J | 1 |
Ponessa, G | 1 |
Isla, MI | 1 |
Saliu, IO | 1 |
Amoo, ZA | 1 |
Khan, MF | 1 |
Olaleye, MT | 1 |
Rema, V | 1 |
Akinmoladun, AC | 1 |
Khan, AU | 1 |
Rahman, AU | 1 |
Yuan, Q | 1 |
Ahmad, A | 1 |
Khan, ZUH | 1 |
Mahnashi, MH | 1 |
Alyami, BA | 1 |
Alqahtani, YS | 1 |
Ullah, S | 1 |
Wirman, AP | 1 |
Gao, M | 1 |
Deng, L | 1 |
Zhang, K | 1 |
Xia, Z | 1 |
Gao, D | 1 |
Balkissou, AD | 1 |
Poka-Mayap, V | 1 |
Massongo, M | 1 |
Djenabou, A | 1 |
Endale-Mangamba, LM | 1 |
Olomo, EJ | 1 |
Boulleys-Nana, JR | 1 |
Diffo-Sonkoue, L | 1 |
Adidigue-Ndiome, R | 1 |
Alexandra, AJE | 1 |
Haman-Wabi, AB | 1 |
Adama, S | 1 |
Iddi-Faical, A | 1 |
Pefura-Yone, EW | 1 |
Zhao, Q | 1 |
Tong, W | 1 |
Ge, C | 1 |
Zhao, D | 1 |
Norbäck, D | 1 |
Li, B | 1 |
Zhao, Z | 1 |
Huang, C | 1 |
Zhang, X | 1 |
Qian, H | 1 |
Yang, X | 1 |
Sun, Y | 1 |
Sundell, J | 1 |
Deng, Q | 1 |
Kim, HJ | 1 |
Jeon, JW | 1 |
Hwang, SM | 1 |
Chu, KI | 1 |
Cha, YH | 1 |
Kwak, YD | 1 |
Choi, SD | 1 |
Aslam, M | 1 |
Kim, CG | 1 |
Zhou, J | 1 |
Yang, E | 1 |
Yang, W | 1 |
Ebert, T | 1 |
Painer, J | 1 |
Bergman, P | 2 |
Qureshi, AR | 2 |
Giroud, S | 1 |
Stalder, G | 1 |
Kublickiene, K | 1 |
Göritz, F | 1 |
Vetter, S | 1 |
Bieber, C | 1 |
Fröbert, O | 1 |
Arnemo, JM | 1 |
Zedrosser, A | 1 |
Redtenbacher, I | 1 |
Shiels, PG | 1 |
Johnson, RJ | 1 |
Stenvinkel, P | 2 |
de Vries, MR | 1 |
Ewing, MM | 1 |
de Jong, RCM | 1 |
MacArthur, MR | 1 |
Karper, JC | 1 |
Peters, EAB | 1 |
Nordzell, M | 1 |
Karabina, SAP | 1 |
Sexton, D | 1 |
Dahlbom, I | 1 |
Bergman, A | 1 |
Mitchell, JR | 1 |
Frostegård, J | 1 |
Kuiper, J | 1 |
Ninio, E | 1 |
Jukema, JW | 1 |
Pettersson, K | 1 |
Quax, PHA | 1 |
Thomas, MS | 1 |
Fernandez, ML | 2 |
Ivey, KL | 1 |
Wang, DD | 2 |
Wilkinson, JE | 1 |
Franke, A | 1 |
Lee, KH | 1 |
Chan, A | 1 |
Huttenhower, C | 1 |
Hu, FB | 2 |
Rimm, EB | 1 |
Sun, Q | 1 |
Pan, XF | 1 |
Moore, SC | 1 |
Palmer, ND | 1 |
Guasch-Ferré, M | 2 |
Herrington, DM | 1 |
Harada, S | 1 |
Eliassen, H | 1 |
Wang, TJ | 1 |
Gerszten, RE | 1 |
Albanes, D | 1 |
Tzoulaki, I | 1 |
Karaman, I | 1 |
Elliott, P | 1 |
Wagenknecht, LE | 1 |
Cai, Q | 1 |
Matthews, CE | 1 |
Menni, C | 1 |
Ose, J | 1 |
Fornage, M | 1 |
Ulrich, CM | 1 |
Zhong, C | 1 |
Miao, M | 1 |
Che, B | 1 |
Du, J | 1 |
Wang, A | 1 |
Peng, H | 1 |
Bu, X | 1 |
Ju, Z | 1 |
He, J | 1 |
Gillies, NA | 1 |
Franzke, B | 1 |
Wessner, B | 1 |
Schober-Halper, B | 1 |
Hofmann, M | 1 |
Oesen, S | 1 |
Tosevska, A | 1 |
Strasser, EM | 1 |
Roy, NC | 1 |
Milan, AM | 1 |
Cameron-Smith, D | 1 |
Wagner, KH | 1 |
Razak, MA | 1 |
Begum, PS | 1 |
Viswanath, B | 1 |
Rajagopal, S | 1 |
Roe, AJ | 1 |
Zhang, S | 1 |
Bhadelia, RA | 1 |
Johnson, EJ | 1 |
Lichtenstein, AH | 1 |
Rogers, GT | 1 |
Rosenberg, IH | 1 |
Smith, CE | 1 |
Zeisel, SH | 3 |
Scott, TM | 1 |
Fernandez-Prado, R | 1 |
Esteras, R | 1 |
Perez-Gomez, MV | 1 |
Gracia-Iguacel, C | 1 |
Gonzalez-Parra, E | 1 |
Sanz, AB | 1 |
Ortiz, A | 1 |
Sanchez-Niño, MD | 1 |
Haissman, JM | 1 |
Haugaard, AK | 1 |
Ostrowski, SR | 1 |
Hov, JR | 2 |
Trøseid, M | 2 |
Nielsen, SD | 1 |
Shea, JW | 1 |
Ruiz-Canela, M | 1 |
Bulló, M | 1 |
Toledo, E | 1 |
Gómez-Gracia, E | 1 |
Fiol, M | 1 |
Fitó, M | 1 |
Arós, F | 1 |
Dennis, C | 1 |
Liang, L | 1 |
Clish, CB | 1 |
Missimer, A | 1 |
DiMarco, DM | 1 |
Norris, GH | 1 |
Blesso, CN | 1 |
Murillo, AG | 1 |
Vergara-Jimenez, M | 1 |
Lemos, BS | 1 |
Medina-Vera, I | 1 |
Cajka, T | 1 |
Buffa, JA | 2 |
Nemet, I | 1 |
Hurd, AG | 1 |
Gu, X | 1 |
Skye, SM | 1 |
Roberts, AB | 1 |
Shahen, CJ | 1 |
Wagner, MA | 1 |
Hartiala, JA | 1 |
Kerby, RL | 1 |
Romano, KA | 1 |
Han, Y | 1 |
Obeid, S | 1 |
Lüscher, TF | 1 |
Allayee, H | 2 |
Rey, FE | 1 |
Fiehn, O | 1 |
Jameson, E | 1 |
Quareshy, M | 1 |
Anwar, S | 1 |
Bhandari, U | 1 |
Panda, BP | 1 |
Dubey, K | 1 |
Khan, W | 1 |
Ahmad, S | 1 |
Crothers, J | 1 |
Bry, L | 1 |
Cassambai, S | 1 |
Salzano, A | 1 |
Yazaki, Y | 1 |
Bernieh, D | 1 |
Wong, M | 1 |
Israr, MZ | 1 |
Heaney, LM | 1 |
Suzuki, T | 1 |
Kalagi, NA | 1 |
Abbott, KA | 1 |
Alburikan, KA | 1 |
Alkofide, HA | 1 |
Stojanovski, E | 1 |
Garg, ML | 1 |
Mazidi, M | 1 |
Katsiki, N | 1 |
Mikhailidis, DP | 1 |
Banach, M | 1 |
Ufnal, M | 1 |
Nowiński, A | 1 |
Tang, WH | 4 |
Levison, BS | 3 |
Koeth, RA | 2 |
Britt, EB | 3 |
Fu, X | 3 |
Stock, J | 1 |
Miller, MJ | 1 |
Fan, Y | 1 |
Moraes, C | 1 |
Fouque, D | 1 |
Amaral, AC | 1 |
Mafra, D | 1 |
Missailidis, C | 1 |
Hällqvist, J | 1 |
Barany, P | 1 |
Heimbürger, O | 1 |
Lindholm, B | 1 |
Obeid, R | 1 |
Awwad, HM | 1 |
Rabagny, Y | 1 |
Graeber, S | 1 |
Herrmann, W | 1 |
Geisel, J | 1 |
Nestvold, TK | 1 |
Thoresen, H | 1 |
Lappegård, KT | 1 |
Millard, HR | 1 |
Musani, SK | 1 |
Dibaba, DT | 1 |
Talegawkar, SA | 1 |
Taylor, HA | 1 |
Tucker, KL | 1 |
Bidulescu, A | 1 |
Wahlang, B | 1 |
Perkins, JT | 1 |
Petriello, MC | 1 |
Hoffman, JB | 1 |
Stromberg, AJ | 1 |
Hennig, B | 1 |
Bi, X | 1 |
Xu, M | 1 |
Xue, R | 1 |
He, X | 1 |
Zang, W | 1 |
McLean, AS | 1 |
Huang, SJ | 1 |
Salter, M | 1 |
Konstantinova, SV | 1 |
Tell, GS | 1 |
Vollset, SE | 1 |
Ulvik, A | 1 |
Drevon, CA | 1 |
Ueland, PM | 1 |
LeLeiko, RM | 1 |
Vaccari, CS | 1 |
Sola, S | 1 |
Merchant, N | 1 |
Nagamia, SH | 1 |
Thoenes, M | 1 |
Khan, BV | 1 |
Lee, JE | 1 |
Jacques, PF | 1 |
Dougherty, L | 1 |
Selhub, J | 1 |
Giovannucci, E | 1 |
Cho, E | 1 |
Förster, S | 1 |
Rominger, A | 1 |
Saam, T | 1 |
Wolpers, S | 1 |
Nikolaou, K | 1 |
Cumming, P | 1 |
Reiser, MF | 1 |
Bartenstein, P | 1 |
Hacker, M | 1 |
Rak, K | 1 |
Rader, DJ | 1 |
Klipfell, E | 1 |
Bennett, BJ | 1 |
Koeth, R | 1 |
Dugar, B | 1 |
Feldstein, AE | 1 |
Chung, YM | 1 |
Schauer, P | 1 |
Smith, JD | 1 |
Lusis, AJ | 1 |
Getz, GS | 1 |
Reardon, CA | 1 |
Bertolo, RF | 1 |
McBreairty, LE | 1 |
Schwahn, BC | 1 |
Chen, Z | 1 |
Laryea, MD | 1 |
Wendel, U | 1 |
Lussier-Cacan, S | 1 |
Genest, J | 1 |
Mar, MH | 1 |
Castro, C | 1 |
Garrow, T | 1 |
Rozen, R | 1 |
WILGRAM, GF | 1 |
BEST, CH | 1 |
BLUMENSTEIN, J | 1 |
CAVALLINI, L | 1 |
COLLINS, DC | 1 |
READ, JT | 1 |
OBETZ, RC | 1 |
SALMON, WD | 1 |
NEWBERNE, PM | 1 |
Olthof, MR | 2 |
Verhoef, P | 2 |
Heinecke, JW | 1 |
Dalmeijer, GW | 1 |
Bots, ML | 1 |
van der Schouw, YT | 1 |
Collinson, PO | 1 |
Gaze, DC | 1 |
Bucerius, J | 1 |
Schmaljohann, J | 1 |
Böhm, I | 1 |
Palmedo, H | 1 |
Guhlke, S | 1 |
Tiemann, K | 1 |
Schild, HH | 1 |
Biersack, HJ | 1 |
Manka, C | 1 |
KRUMMEL, W | 1 |
Glade, MJ | 1 |
Lang, G | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
BASEL VIII Trial - Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia[NCT01838148] | 4,000 participants (Anticipated) | Observational | 2004-05-31 | Recruiting | |||
ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis[NCT02328677] | 5,000 participants (Anticipated) | Observational | 2007-03-31 | Recruiting | |||
Inner Mongolia Stroke Project A Randomized Controlled Trial of Immediate Blood Pressure Reduction on Death and Major Disability in Patients With Acute Ischemic Stroke in China[NCT01840072] | 4,071 participants (Actual) | Interventional | 2009-08-31 | Completed | |||
The Effects of Glycine on Atherosclerosis and Metabolic Syndrome-related Parameters: A Clinical and Ex-vivo Study.[NCT03850314] | Phase 2/Phase 3 | 50 participants (Anticipated) | Interventional | 2019-03-31 | Not yet recruiting | ||
Effects of a Whole Food Based Nutritional Formulation on Trimethylamine N-oxide and Cardiometabolic Endpoints in Healthy Adults.[NCT05795946] | 45 participants (Anticipated) | Interventional | 2023-04-15 | Recruiting | |||
Effect of Choline Source and Gut Microbiota Composition on Trimethylamine-N-oxide Response in Humans[NCT04255368] | 44 participants (Actual) | Interventional | 2017-11-09 | Completed | |||
"Plant-Based Meat vs Animal Red Meat: a Randomized Cross-over Trial"[NCT04510324] | 41 participants (Actual) | Interventional | 2020-11-01 | Completed | |||
Does the Human Gut Microbiome Serve as a Novel Personalized Therapeutic Target for Coronary Atherosclerosis?[NCT03009565] | 800 participants (Anticipated) | Observational | 2017-01-31 | Not yet recruiting | |||
GutHeart: Targeting Gut Microbiota to Treat Heart Failure[NCT02637167] | Phase 2 | 150 participants (Anticipated) | Interventional | 2016-03-11 | Recruiting | ||
Impact of Facilitated Vegan Diet on Cardiometabolic Endpoints and Trimethylamine N-oxide[NCT05071196] | 70 participants (Anticipated) | Interventional | 2022-01-01 | Active, not recruiting | |||
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)[NCT02016430] | 150 participants (Anticipated) | Interventional | 2014-04-04 | Recruiting | |||
Analysis of MicroBial Metabolites After Eating Refined Food[NCT04308473] | 46 participants (Actual) | Interventional | 2020-09-01 | Active, not recruiting | |||
Evaluation of Red Wine Effects Upon Gut Flora and Plasma Levels of Trimethylamine-N-oxide (TMAO) in Patients With Established Atherosclerotic Disease[NCT03232099] | 42 participants (Actual) | Interventional | 2016-08-31 | Completed | |||
A Trial of the Ideal Protein System Versus Low Fat Diet for Weight Loss[NCT03515889] | 192 participants (Actual) | Interventional | 2018-05-23 | Completed | |||
Effect of Probiotic Supplementation on Endothelial Function II[NCT03267758] | 215 participants (Anticipated) | Interventional | 2018-05-15 | Recruiting | |||
Effect of 1 Year Vitamin D or D Plus B-vitamins on Bone Markers in Elderly People[NCT02586181] | 93 participants (Actual) | Interventional | 2009-08-31 | Completed | |||
B-Vitamins and Polyneuropathy in Patients With Type 2 Diabetes[NCT02588898] | 212 participants (Actual) | Observational | 2009-09-30 | Completed | |||
Molecular Imaging of Plaque Vulnerability Using 18F-choline PET-MRI in Carotid Artery Atherosclerosis Patients[NCT02640313] | Phase 3 | 14 participants (Anticipated) | Interventional | 2015-12-31 | Recruiting | ||
Low Fat Vegan Diet or American Heart Association Diet, Impact on Biomarkers of Inflammation, Oxidative Stress and Cardiovascular Risk in Obese 9-18 y.o. With Elevated Cholesterol: A Four Week Randomized Trial[NCT01817491] | 60 participants (Actual) | Interventional | 2013-03-31 | Completed | |||
Effects of Choline Supplementation on Fetal Growth in Gestational Diabetes Mellitus[NCT04302168] | 60 participants (Anticipated) | Interventional | 2020-04-01 | Recruiting | |||
Impact of Diet and Gut Microbiota on Trimethylamine-N-oxide Production and Fate in Humans[NCT02558673] | 40 participants (Actual) | Interventional | 2014-05-31 | Completed | |||
Effects of Choline From Eggs vs. Supplements on the Generation of TMAO in Humans (EGGS)[NCT03039023] | 86 participants (Actual) | Interventional | 2016-09-02 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Major disability was defined as a score of 3 to 5 on the modified Rankin Scale at 3 months after randomization. Scores on the modified Rankin Scale range from 0 to 6, with a score of 0 indicating no symptoms; a score of 5 indicating severe disability (ie, bedridden, incontinent, or requiring constant nursing care and attention); and a score of 6 indicating death (NCT01840072)
Timeframe: 3 months
Intervention | Participants (Count of Participants) |
---|---|
Usual Care | 502 |
Active Antihypertensive Treatment | 500 |
Major disability was defined as a score of 3 to 5 on the modified Rankin Scale at 14 days after randomization. Scores on the modified Rankin Scale range from 0 to 6, with a score of 0 indicating no symptoms; a score of 5 indicating severe disability (ie, bedridden, incontinent, or requiring constant nursing care and attention); and a score of 6 indicating death. (NCT01840072)
Timeframe: 2 weeks
Intervention | participants (Number) |
---|---|
Usual Care | 681 |
Active Antihypertensive Treatment | 683 |
Cognitive function was measured by Montreal Cognitive Assessment at 3 months after randomization. The MoCA is a 30-item test that evaluates the following seven cognitive domains: visuospatial/executive functions, naming, memory, attention, language, abstraction, and orientation. One point is added for participants with education <12 years. Scores on the MoCA range from 0 to 30 and cognitive impairment was defined as a score of <26. (NCT01840072)
Timeframe: Three months
Intervention | MoCA score (Median) |
---|---|
Usual Care | 22 |
Active Antihypertensive Treatment | 22 |
Cognitive function was measured by the Mini-Mental State Examination at 3 months after randomization. The MMSE contains 20 items that test cognitive performance in domains including orientation, registration, attention and calculation, recall, language, and visual construction. MMSE scores were divided into three ordinal categories: 24-30 (no cognitive impairment), 19-23 (mild cognitive impairment), and 0-17 (severe cognitive impairment). (NCT01840072)
Timeframe: Three months
Intervention | MMSE score (Median) |
---|---|
Usual Care | 26 |
Active Antihypertensive Treatment | 26 |
Those patients who were still alive at hospital discharge were contacted by telephone to set up a follow-up clinical visit. Neurological function was assessed by the modified Rankin scale at the 3-month post-treatment follow-up visit. Scores on the modified Rankin Scale range from 0 to 6, with a score of 0 indicating no symptoms; a score of 5 indicating severe disability (ie, bedridden, incontinent, or requiring constant nursing care and attention); and a score of 6 indicating death. Major disability was defined as a score of 3 to 5 on the modified Rankin Scale. (NCT01840072)
Timeframe: Three months
Intervention | Score on modified Rankin scale (Median) |
---|---|
Usual Care | 1.0 |
Active Antihypertensive Treatment | 1.0 |
Those patients who are still alive at hospital discharge will be contacted by telephone to set up a follow-up clinical visit. Information on clinical deaths will be obtained. (NCT01840072)
Timeframe: 3 months
Intervention | participants (Number) |
---|---|
Active Antihypertensive Treatment | 68 |
Usual Care | 54 |
Those patients who are still alive at hospital discharge will be contacted by telephone to set up a follow-up clinical visit. Information of vascular events, such as myocardial infarction, will be collected. (NCT01840072)
Timeframe: 3 months
Intervention | participants (Number) |
---|---|
Usual Care | 59 |
Active Antihypertensive Treatment | 48 |
Those patients who are still alive at hospital discharge will be contacted by telephone to set up a follow-up clinical visit. Information of recurrent stroke will be collected. (NCT01840072)
Timeframe: 3 months
Intervention | participants (Number) |
---|---|
Active Antihypertensive Treatment | 28 |
Usual Care | 43 |
PAQ self reported questions based on activity level from 1 (low activity) to 5 (high activity), overall PAQ score is a mean of the questions. (NCT01817491)
Timeframe: baseline, 4 weeks
Intervention | units on a scale (Mean) |
---|---|
Reduced Fat Vegan Diet | 0.22 |
American Heart Association Diet | -0.16 |
Body mass index z-scores, also called BMI standard deviation (s.d.) scores, are measures of relative weight adjusted for child age and sex. Given a child's age, sex, BMI, and an appropriate reference standard, a BMI z-score (or its equivalent BMI-for-age percentile) can be determined. Negative BMI z-scores indicate a BMI that is lower than the population mean, while positive BMI scores indicate a value that is higher than the population mean. A decrease in the BMI z-score over time indicate a lowering of the BMI. Z-scores of 1.03 and 1.64 correspond to the 85th and 95th percentiles of BMI-for-age, which are the definitions of overweight and obesity in children. (NCT01817491)
Timeframe: baseline, 4 weeks
Intervention | Z Score (Mean) |
---|---|
Reduced Fat Vegan Diet | -0.14 |
American Heart Association Diet | -0.03 |
(NCT01817491)
Timeframe: Baseline, 4 weeks
Intervention | Z score (Mean) |
---|---|
PB/AHA | -0.13 |
PAQ self reported questions based on activity level from 1 (low activity) to 5 (high activity), overall PAQ score is a mean of the questions. (NCT01817491)
Timeframe: Baseline, 4 weeks
Intervention | units on a scale (Mean) |
---|---|
PB/AHA | 0.39 |
(NCT01817491)
Timeframe: baseline, 4 weeks
Intervention | mm Hg (Mean) | |||
---|---|---|---|---|
Children Systolic BP | Parents Systolic BP | Children Diastolic BP | Parent Diastolic BP | |
American Heart Association Diet | -5.14 | -3.14 | -4.36 | -6.64 |
Reduced Fat Vegan Diet | -6.43 | -7.96 | -2.61 | -3.46 |
(NCT01817491)
Timeframe: baseline, 4 weeks
Intervention | BMI percentile (Mean) | |
---|---|---|
Children | Parents | |
American Heart Association Diet | -0.08 | -0.73 |
Reduced Fat Vegan Diet | -1.12 | -1.29 |
(NCT01817491)
Timeframe: baseline, 4 weeks
Intervention | cm (Mean) | |||
---|---|---|---|---|
Children Waist Circumference | Parents Waist Circumference | Children Midarm Circumference | Parents Midarm Circumference | |
American Heart Association Diet | -2.96 | -0.49 | -1.14 | 0.35 |
Reduced Fat Vegan Diet | -1.53 | -1.94 | -2.02 | -1.32 |
(NCT01817491)
Timeframe: baseline, 4 weeks
Intervention | mg/dL (Mean) | |
---|---|---|
Children | Parent | |
American Heart Association Diet | -.64 | -5.43 |
Reduced Fat Vegan Diet | 0.93 | 4.93 |
(NCT01817491)
Timeframe: baseline, 4 weeks
Intervention | percentage (Mean) | |
---|---|---|
Children | Parent | |
American Heart Association Diet | 0.21 | 0.14 |
Reduced Fat Vegan Diet | 0.17 | -0.16 |
(NCT01817491)
Timeframe: baseline, 4 weeks
Intervention | mg/L (Mean) | |
---|---|---|
Children | Parent | |
American Heart Association Diet | 2.78 | 0.21 |
Reduced Fat Vegan Diet | -2.09 | -0.24 |
(NCT01817491)
Timeframe: baseline, 4 weeks
Intervention | pg/ml (Mean) | |
---|---|---|
Children | Parent | |
American Heart Association Diet | -0.19 | -0.19 |
Reduced Fat Vegan Diet | -0.17 | 0.16 |
(NCT01817491)
Timeframe: baseline, 4 weeks
Intervention | uU/ml (Mean) | |
---|---|---|
Children | Parents | |
American Heart Association Diet | 3.16 | -3.15 |
Reduced Fat Vegan Diet | -5.42 | -3.11 |
(NCT01817491)
Timeframe: baseline, 4 weeks
Intervention | mg/dL (Mean) | |||||||
---|---|---|---|---|---|---|---|---|
total cholesterol children | triglycerides children | high-density lipoprotein cholesterol children | low-density lipoprotein cholesterol children | total cholesterol parents | triglycerides parents | high-density lipoprotein cholesterol parents | low-density lipoprotein cholesterol parents | |
American Heart Association Diet | -16.50 | -13.14 | -2.93 | -11.00 | -7.14 | 16.86 | 16.86 | -5.50 |
Reduced Fat Vegan Diet | -22.50 | -25.50 | -5.93 | -13.14 | -33.79 | 6.21 | -8.14 | -27.00 |
(NCT01817491)
Timeframe: baseline, 4 weeks
Intervention | U/L (Mean) | |||
---|---|---|---|---|
alanine aminotransferase (ALT) children | aspartate aminotransferase (AST) children | alanine aminotransferase (ALT) parents | aspartate aminotransferase (AST) parents | |
American Heart Association Diet | -1.14 | 0.00 | 4.57 | 4.43 |
Reduced Fat Vegan Diet | 0.79 | 2.79 | 0.86 | 0.14 |
(NCT01817491)
Timeframe: baseline, 4 weeks
Intervention | pmol/L (Mean) | |
---|---|---|
Children | Parent | |
American Heart Association Diet | -69.23 | 1.78 |
Reduced Fat Vegan Diet | -75.34 | 16.91 |
(NCT01817491)
Timeframe: baseline, 4 weeks
Intervention | kg (Mean) | |
---|---|---|
Children | Parents | |
American Heart Association Diet | -1.55 | -2.01 |
Reduced Fat Vegan Diet | -3.05 | -3.64 |
(NCT01817491)
Timeframe: Baseline, 4 weeks
Intervention | ratio (Mean) | |||
---|---|---|---|---|
Children adj mean ratio systolic BP | Children adj mean ratio diastolic BP | parents adj mean ratio systolic BP | parents adj mean ratio diastolic BP | |
PB/AHA | 1.87 | 1.01 | 0.97 | 1.03 |
(NCT01817491)
Timeframe: Baseline, 4 weeks
Intervention | percentile (Mean) | |
---|---|---|
Children Change in BMI | Parents Change in BMI | |
PB/AHA | -1.17 | -0.69 |
(NCT01817491)
Timeframe: Baseline, 4 weeks
Intervention | cm (Mean) | |||
---|---|---|---|---|
children waist circumference | parents waist circumference | children arm circumference | parents arm circumference | |
PB/AHA | 1.32 | -1.14 | -1.25 | -1.68 |
(NCT01817491)
Timeframe: Baseline, 4 weeks
Intervention | kg (Mean) | |
---|---|---|
Children Weight | Parents Weight | |
PB/AHA | -1.71 | -1.95 |
(NCT01817491)
Timeframe: Baseline, 4 weeks
Intervention | mg/dL (Mean) | |||||||
---|---|---|---|---|---|---|---|---|
CHOL children | TRIG children | HDL children | LDL children | CHOL parents | TRIG parents | HDL parents | LDL parents | |
PB/AHA | -10.34 | 1.01 | 0.17 | 0.95 | -27.29 | 0.95 | 0.94 | -21.92 |
(NCT01817491)
Timeframe: Baseline, 4 weeks
Intervention | ratio (Mean) | |
---|---|---|
Children | Parents | |
PB/AHA | 1.01 | 1.06 |
(NCT01817491)
Timeframe: Baseline, 4 weeks
Intervention | ratio (Mean) | |
---|---|---|
Children | Parents | |
PB/AHA | 0.99 | 0.96 |
(NCT01817491)
Timeframe: Baseline, 4 weeks
Intervention | ratio (Mean) | |
---|---|---|
Children | Parents | |
PB/AHA | 0.46 | 0.68 |
(NCT01817491)
Timeframe: Baseline, 4 weeks
Intervention | ratio (Mean) | |
---|---|---|
Children | Parents | |
PB/AHA | 0.26 | 1.14 |
(NCT01817491)
Timeframe: Baseline, 4 weeks
Intervention | ratio (Mean) | |
---|---|---|
Children | Parents | |
PB/AHA | 0.7 | 0.87 |
(NCT01817491)
Timeframe: Baseline, 4 weeks
Intervention | ratio (Mean) | |||
---|---|---|---|---|
ALT children | AST children | ALT parents | AST parents | |
PB/AHA | 1 | 1.13 | 0.85 | 0.83 |
(NCT01817491)
Timeframe: Baseline, 4 weeks
Intervention | ratio (Mean) | |
---|---|---|
Children | Parents | |
PB/AHA | 0.95 | 0.93 |
Changes in levels of non-labeled TMAO from baseline to Day 28 measured by established mass spectrometry techniques. (NCT03039023)
Timeframe: Baseline, Day 28
Intervention | mg in 24 hours (Median) | |
---|---|---|
Baseline | Day 28 | |
Choline Bitartrate Tablets | 26.2 | 139.0 |
Egg Whites + Choline Bitartrate Tablets | 29.3 | 186.9 |
Hardboiled Eggs + Choline Bitartrate Tablets | 27.5 | 221.8 |
Phosphatidylcholine Capsules | 15.8 | 33.1 |
Whole Hardboiled Eggs | 24.3 | 28.5 |
Changes in measured HDL levels between baseline and Day 28 (NCT03039023)
Timeframe: Baseline, Day 28
Intervention | mg/dL (Median) | |
---|---|---|
Baseline | Day 28 | |
Choline Bitartrate Tablets | 49 | 51 |
Egg Whites + Choline Bitartrate Tablets | 48 | 50 |
Hardboiled Eggs + Choline Bitartrate Tablets | 57 | 56 |
Phosphatidylcholine Capsules | 61 | 62 |
Whole Hardboiled Eggs | 48 | 49 |
Changes in measured LDL levels between baseline and Day 28 (NCT03039023)
Timeframe: Baseline, Day 28
Intervention | mg/dL (Median) | |
---|---|---|
Baseline | Day 28 | |
Choline Bitartrate Tablets | 90 | 94 |
Egg Whites + Choline Bitartrate Tablets | 104 | 101 |
Hardboiled Eggs + Choline Bitartrate Tablets | 108 | 118 |
Phosphatidylcholine Capsules | 107 | 106 |
Whole Hardboiled Eggs | 91 | 86 |
Changes in total cholesterol levels between baseline and Day 28 (NCT03039023)
Timeframe: Baseline, Day 28
Intervention | mg/dL (Median) | |
---|---|---|
Baseline | Day 28 | |
Choline Bitartrate Tablets | 180 | 172 |
Egg Whites + Choline Bitartrate Tablets | 186 | 178 |
Hardboiled Eggs + Choline Bitartrate Tablets | 187 | 198 |
Phosphatidylcholine Capsules | 175 | 172 |
Whole Hardboiled Eggs | 156 | 158 |
Changes in measured triglyceride levels between baseline and Day 28 (NCT03039023)
Timeframe: Baseline, Day 28
Intervention | mg/dL (Median) | |
---|---|---|
Baseline | Day 28 | |
Choline Bitartrate Tablets | 106 | 96 |
Egg Whites + Choline Bitartrate Tablets | 122 | 109 |
Hardboiled Eggs + Choline Bitartrate Tablets | 103 | 97 |
Phosphatidylcholine Capsules | 74 | 84 |
Whole Hardboiled Eggs | 86 | 100 |
Fasting plasma levels of betaine from samples obtained at baseline and at day 28 were compared. (NCT03039023)
Timeframe: Baseline, Day 28
Intervention | uM (Median) | |
---|---|---|
Baseline | Day 28 | |
Choline Bitartrate Tablets | 38.2 | 69.0 |
Egg Whites + Choline Bitartrate Tablets | 38.7 | 59.8 |
Hardboiled Eggs + Choline Bitartrate Tablets | 30.7 | 46.9 |
Phosphatidylcholine Capsules | 33.6 | 46.3 |
Whole Hardboiled Eggs | 28.1 | 39.7 |
Fasting plasma levels of carnitine from samples obtained at baseline and at day 28 were compared. (NCT03039023)
Timeframe: Baseline, Day 28
Intervention | uM (Median) | |
---|---|---|
Baseline | Day 28 | |
Choline Bitartrate Tablets | 21.2 | 18.7 |
Egg Whites + Choline Bitartrate Tablets | 21.1 | 18.9 |
Hardboiled Eggs + Choline Bitartrate Tablets | 21.5 | 15.6 |
Phosphatidylcholine Capsules | 23.4 | 20.8 |
Whole Hardboiled Eggs | 19.1 | 19.4 |
Fasting plasma levels of choline from samples obtained at baseline and at day 28 were compared. (NCT03039023)
Timeframe: Baseline, Day 28
Intervention | uM (Median) | |
---|---|---|
Baseline | Day 28 | |
Choline Bitartrate Tablets | 7.5 | 12.9 |
Egg Whites + Choline Bitartrate Tablets | 9.5 | 12.8 |
Hardboiled Eggs + Choline Bitartrate Tablets | 8.5 | 14.0 |
Phosphatidylcholine Capsules | 7.6 | 10.6 |
Whole Hardboiled Eggs | 8.3 | 10.9 |
Changes in levels of non-labeled TMAO from baseline to end-of-study (day 28) as measured by established techniques by mass spectrometry. (NCT03039023)
Timeframe: Baseline, 28 days
Intervention | uM (Median) | |
---|---|---|
Baseline | Day 28 | |
Choline Bitartrate Tablets | 1.9 | 11.1 |
Egg Whites + Choline Bitartrate Tablets | 2.6 | 28.1 |
Hardboiled Eggs + Choline Bitartrate Tablets | 2.3 | 12.3 |
Phosphatidylcholine Capsules | 2.8 | 3.4 |
Whole Hardboiled Eggs | 2.0 | 2.3 |
The activation and functioning of platelets within a single subject will be compared before and after increased choline intake. (NCT03039023)
Timeframe: Baseline, Day 28
Intervention | aggregation percentage (Median) | |
---|---|---|
Baseline | Day 28 | |
Choline Bitartrate Tablets | 2.6 | 12.8 |
Egg Whites + Choline Bitartrate Tablets | 3.0 | 29.4 |
Hardboiled Eggs + Choline Bitartrate Tablets | 2.3 | 12.3 |
Phosphatidylcholine Capsules | 2.8 | 3.4 |
Whole Hardboiled Eggs | 2.6 | 3.6 |
23 reviews available for choline and Cardiovascular Diseases
Article | Year |
---|---|
Are eggs good again? A precision nutrition perspective on the effects of eggs on cardiovascular risk, taking into account plasma lipid profiles and TMAO.
Topics: Bacteria; Biological Variation, Population; Cardiovascular Diseases; Cholesterol; Choline; Diet; Egg | 2022 |
Trimethylamine N-oxide reduction is related to probiotic strain specificity: A systematic review.
Topics: Animals; Cardiovascular Diseases; Choline; Gastrointestinal Microbiome; Humans; Methylamines; Probio | 2022 |
Microbiota Effect on Trimethylamine N-Oxide Production: From Cancer to Fitness-A Practical Preventing Recommendation and Therapies.
Topics: Animals; Cardiovascular Diseases; Choline; Inflammation; Methylamines; Microbiota; Neoplasms | 2023 |
The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases.
Topics: Atherosclerosis; Cardiovascular Diseases; Choline; Gastrointestinal Microbiome; Humans; Methylamines | 2023 |
Association of choline and betaine with the risk of cardiovascular disease and all-cause mortality: Meta-analysis.
Topics: Betaine; Cardiovascular Diseases; Choline; Humans; Observational Studies as Topic; Prospective Studi | 2023 |
The Gut Microbiota Affects Host Pathophysiology as an Endocrine Organ: A Focus on Cardiovascular Disease.
Topics: Animals; Atherosclerosis; Bile Acids and Salts; Cardiovascular Diseases; Choline; Diet; Endocrine Gl | 2019 |
Vitamin B Supplementation and Nutritional Intake of Methyl Donors in Patients with Chronic Kidney Disease: A Critical Review of the Impact on Epigenetic Machinery.
Topics: Betaine; Cardiovascular Diseases; Choline; Dietary Supplements; DNA Methylation; Eating; Epigenesis, | 2020 |
Gut Microbiota and Cardiovascular Disease.
Topics: Animals; Atherosclerosis; Bile Acids and Salts; Cardiovascular Diseases; Carnitine; Choline; Disease | 2020 |
The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases.
Topics: Animals; Biological Availability; Cardiovascular Diseases; Choline; Diet; Dysbiosis; Gastrointestina | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Trimethylamine N-Oxide (TMAO), Diet and Cardiovascular Disease.
Topics: Cardiovascular Diseases; Choline; Diet; Humans; Methylamines | 2021 |
Multifarious Beneficial Effect of Nonessential Amino Acid, Glycine: A Review.
Topics: Animals; Cardiovascular Diseases; Choline; Dietary Supplements; Glycine; Humans; Kidney; Liver; Meta | 2017 |
Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.
Topics: Cardiovascular Diseases; Carnitine; Choline; Diet; Gastrointestinal Microbiome; Humans; Methylamines | 2017 |
Dietary Choline and Betaine and Risk of CVD: A Systematic Review and Meta-Analysis of Prospective Studies.
Topics: Adult; Aged; Betaine; Cardiovascular Diseases; Choline; Diet; Female; Humans; Male; Middle Aged; Pro | 2017 |
Methodological considerations for the identification of choline and carnitine-degrading bacteria in the gut.
Topics: Amino Acid Sequence; Cardiovascular Diseases; Carnitine; Choline; Computational Biology; Diet; Gastr | 2018 |
Modulation of Circulating Trimethylamine N-Oxide Concentrations by Dietary Supplements and Pharmacological Agents: A Systematic Review.
Topics: Anti-Bacterial Agents; Antioxidants; Cardiovascular Diseases; Carnitine; Choline; Dietary Supplement | 2019 |
Dietary choline is positively related to overall and cause-specific mortality: results from individuals of the National Health and Nutrition Examination Survey and pooling prospective data.
Topics: Adult; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Choline; Diet; Ethni | 2019 |
The contributory role of gut microbiota in cardiovascular disease.
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Carnitine; Choline; Diet; Female; Food; Humans; I | 2014 |
Trimethylamine N-Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet.
Topics: Animals; Cardiovascular Diseases; Carnitine; Choline; Diet, Protein-Restricted; Disease Models, Anim | 2015 |
Bench-to-bedside review: the value of cardiac biomarkers in the intensive care patient.
Topics: Biomarkers; CA-125 Antigen; Cardiovascular Diseases; CD40 Ligand; Choline; Creatine Kinase, MB Form; | 2008 |
The nutritional burden of methylation reactions.
Topics: Animals; Betaine; Cardiovascular Diseases; Choline; Creatine; Diet; Dietary Supplements; Folic Acid; | 2013 |
Effects of betaine intake on plasma homocysteine concentrations and consequences for health.
Topics: Animals; Betaine; Cardiovascular Diseases; Choline; Folic Acid; Homocysteine; Humans; Lipids | 2005 |
Biomarkers of cardiovascular damage.
Topics: Biomarkers; Cardiovascular Diseases; Choline; Electrocardiography; Fatty Acids, Nonesterified; Human | 2007 |
7 trials available for choline and Cardiovascular Diseases
Article | Year |
---|---|
One-year longitudinal association between changes in dietary choline or betaine intake and cardiometabolic variables in the PREvención con DIeta MEDiterránea-Plus (PREDIMED-Plus) trial.
Topics: Aged; Betaine; Cardiovascular Diseases; Choline; Diet, Mediterranean; Female; Humans; Male; Mediterr | 2022 |
Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-
Topics: Adult; Biomarkers; Cardiovascular Diseases; Choline; Cross-Over Studies; Diet; Dietary Supplements; | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; | 2022 |
Nutritional supplementation alters associations between one-carbon metabolites and cardiometabolic risk profiles in older adults: a secondary analysis of the Vienna Active Ageing Study.
Topics: Aged; Aging; Betaine; Carbon; Cardiovascular Diseases; Choline; Dietary Supplements; Female; Homocys | 2022 |
Plasma Metabolites From Choline Pathway and Risk of Cardiovascular Disease in the PREDIMED (Prevention With Mediterranean Diet) Study.
Topics: Aged; Aged, 80 and over; Betaine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Chi-Squ | 2017 |
Compared to an Oatmeal Breakfast, Two Eggs/Day Increased Plasma Carotenoids and Choline without Increasing Trimethyl Amine N-Oxide Concentrations.
Topics: Adolescent; Adult; Antioxidants; Avena; Biomarkers; Breakfast; Cardiovascular Diseases; Carotenoids; | 2018 |
[The value of the circulation time determination by the decholine-ether-test in the evaluation of the postoperative cardiovascular stalus].
Topics: Arm; Blood Circulation Time; Cardiovascular Diseases; Choline; Clinical Trials as Topic; Ethers; Hea | 1967 |
51 other studies available for choline and Cardiovascular Diseases
Article | Year |
---|---|
Association between dietary choline and betaine intake and 10.6-year cardiovascular disease in adults.
Topics: Adult; Betaine; Cardiovascular Diseases; Choline; Cohort Studies; Diet; Humans; Iran; Prospective St | 2022 |
Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
Topics: Betaine; Cardiovascular Diseases; Carnitine; Choline; Coronary Artery Disease; Gastrointestinal Micr | 2022 |
Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults.
Topics: Aged; Betaine; Cardiovascular Diseases; Carnitine; Choline; Cohort Studies; Female; Humans; Male; Me | 2022 |
TMAO Upregulates Members of the miR-17/92 Cluster and Impacts Targets Associated with Atherosclerosis.
Topics: Animals; Atherosclerosis; Betaine; Cardiovascular Diseases; Carnitine; Choline; Humans; Inflammation | 2022 |
Choline and trimethylamine N-oxide supplementation in normal chow diet and western diet promotes the development of atherosclerosis in Apoe -/- mice through different mechanisms.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cardiovascular Diseases; Choline; Diet, Western; Dietar | 2023 |
Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
Topics: Adolescent; Adult; Betaine; Blood Glucose; Cardiovascular Diseases; Carnitine; Choline; Female; Gast | 2019 |
Associations of choline-related nutrients with cardiometabolic and all-cause mortality: results from 3 prospective cohort studies of blacks, whites, and Chinese.
Topics: Adult; Aged; Asian People; Black People; Cardiovascular Diseases; Choline; Female; Humans; Male; Mid | 2020 |
Associations of plasma trimethylamine N-oxide, choline, carnitine, and betaine with inflammatory and cardiometabolic risk biomarkers and the fecal microbiome in the Multiethnic Cohort Adiposity Phenotype Study.
Topics: Adiposity; Aged; Bacteria; Betaine; Biomarkers; Cardiovascular Diseases; Carnitine; Choline; Cohort | 2020 |
Population studies of TMAO and its precursors may help elucidate mechanisms.
Topics: Adiposity; Betaine; Biomarkers; Cardiovascular Diseases; Carnitine; Choline; Humans; Methylamines; M | 2020 |
Association of life style and dietary habits with blood choline and cardiovascular outcome.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Choline; Feeding Behavior; Humans; Life Style; | 2020 |
Preventive therapy of antioxidant vitamins against the blood choline levels in cardiovascular patients.
Topics: Adult; Antioxidants; Cardiovascular Diseases; Choline; Humans; Lipids; Middle Aged; Vitamins | 2020 |
Insights in the regulation of trimetylamine N-oxide production using a comparative biomimetic approach suggest a metabolic switch in hibernating bears.
Topics: Adult; Aged; Aged, 80 and over; Animals; Betaine; Biomimetics; Cardiovascular Diseases; Choline; Fem | 2020 |
Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Atherosclerosis; Cardiovascular Diseases; | 2021 |
Interplay between diet and gut microbiome, and circulating concentrations of trimethylamine N-oxide: findings from a longitudinal cohort of US men.
Topics: Cardiovascular Diseases; Choline; Diet; Gastrointestinal Microbiome; Humans; Male; Methylamines | 2022 |
Associations of circulating choline and its related metabolites with cardiometabolic biomarkers: an international pooled analysis.
Topics: Betaine; Biomarkers; Cardiovascular Diseases; Carnitine; Choline; Creatinine; Cross-Sectional Studie | 2021 |
Plasma choline and betaine and risks of cardiovascular events and recurrent stroke after ischemic stroke.
Topics: Aged; Betaine; Cardiovascular Diseases; Case-Control Studies; Choline; Female; Humans; Lipotropic Ag | 2021 |
Choline and its metabolites are differently associated with cardiometabolic risk factors, history of cardiovascular disease, and MRI-documented cerebrovascular disease in older adults.
Topics: Aged; Aged, 80 and over; Betaine; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cere | 2017 |
Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
Topics: Adult; Betaine; Biomarkers; Blood Platelets; Cardiovascular Diseases; Carnitine; Choline; Cross-Sect | 2017 |
Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk.
Topics: Aged; Animals; Atherosclerosis; Cardiovascular Diseases; Carnitine; Cholesterol; Choline; Disease Mo | 2018 |
Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk.
Topics: Adult; Alkaloids; Animals; Cardiovascular Diseases; Choline; Female; Gastrointestinal Microbiome; Hu | 2018 |
Gutting TMA to Save the Heart.
Topics: Animals; Cardiovascular Diseases; Choline; Diet; Gastrointestinal Microbiome; Gastrointestinal Tract | 2018 |
Impact of acute choline loading on circulating trimethylamine N-oxide levels.
Topics: Biomarkers; Cardiovascular Diseases; Choline; Diet; Healthy Volunteers; Humans; Lipotropic Agents; M | 2019 |
Is increased plasma TMAO a compensatory response to hydrostatic and osmotic stress in cardiovascular diseases?
Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Carnitine; Choline; Diet; Humans; Hydrostat | 2019 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Betaine; Cardiovascular Diseases; Choline; Female | 2013 |
Gut microbiota: an environmental risk factor for cardiovascular disease.
Topics: Cardiovascular Diseases; Choline; Diet, Mediterranean; Environment; Environmental Pollutants; Humans | 2013 |
Risk factors for cardiovascular disease: a cautionary tale of diet-microbiome interactions.
Topics: Cardiovascular Diseases; Carnitine; Choline; Diet; Gastrointestinal Tract; Humans; Methylamines; Mic | 2013 |
Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.
Topics: Animals; Betaine; Cardiovascular Diseases; Choline; Female; Humans; Intestinal Mucosa; Kaplan-Meier | 2014 |
Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
Topics: Adult; Aged; Betaine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Choline; Female; Fibr | 2016 |
Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism.
Topics: Aged; Bacteria; Betaine; Cardiovascular Diseases; Choline; Creatinine; Diabetes Mellitus; Female; Ga | 2016 |
Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism.
Topics: Aged; Bacteria; Betaine; Cardiovascular Diseases; Choline; Creatinine; Diabetes Mellitus; Female; Ga | 2016 |
Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism.
Topics: Aged; Bacteria; Betaine; Cardiovascular Diseases; Choline; Creatinine; Diabetes Mellitus; Female; Ga | 2016 |
Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism.
Topics: Aged; Bacteria; Betaine; Cardiovascular Diseases; Choline; Creatinine; Diabetes Mellitus; Female; Ga | 2016 |
Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
Topics: Adult; Atherosclerosis; Bariatric Surgery; Betaine; Body Mass Index; Cardiovascular Diseases; Carnit | 2016 |
Dietary choline and betaine; associations with subclinical markers of cardiovascular disease risk and incidence of CVD, coronary heart disease and stroke: the Jackson Heart Study.
Topics: Adult; Aged; Aged, 80 and over; Betaine; Black People; Cardiovascular Diseases; Choline; Coronary Di | 2018 |
A compromised liver alters polychlorinated biphenyl-mediated toxicity.
Topics: Adipokines; Animals; Aroclors; Biomarkers; Blood Glucose; Cardiovascular Diseases; Choline; Diet; Di | 2017 |
Choline ameliorates cardiovascular damage by improving vagal activity and inhibiting the inflammatory response in spontaneously hypertensive rats.
Topics: Animals; Baroreflex; Cardiomegaly; Cardiovascular Diseases; Choline; Cytokines; Disease Models, Anim | 2017 |
Dietary patterns, food groups, and nutrients as predictors of plasma choline and betaine in middle-aged and elderly men and women.
Topics: Aged; Betaine; Bread; Cardiovascular Diseases; Choline; Cohort Studies; Diet Surveys; Dietary Fats; | 2008 |
Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cardiovascular Dis | 2009 |
Are dietary choline and betaine intakes determinants of total homocysteine concentration?
Topics: Betaine; Cardiovascular Diseases; Choline; Cognition Disorders; Diet; Female; Folic Acid; Homocystei | 2010 |
18F-fluoroethylcholine uptake in arterial vessel walls and cardiovascular risk factors: correlation in a PET-CT study.
Topics: Aged; Calcinosis; Cardiovascular Diseases; Choline; Fluorine Radioisotopes; Humans; Male; Middle Age | 2010 |
Cardiovascular disease: the diet-microbe morbid union.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Choline; Diet; Dietary Fats; | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Topics: Animals; Atherosclerosis; Betaine; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Choline; D | 2011 |
Atherosclerosis: beyond cholesterol.
Topics: Animals; Atherosclerosis; Carbohydrate Metabolism; Cardiovascular Diseases; Choline; Dietary Fats; G | 2011 |
Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency.
Topics: Animals; Betaine; Cardiovascular Diseases; Choline; Dose-Response Relationship, Drug; Female; Genoty | 2003 |
Effect of growth hormone and testosterone on induction of cardiovascular changes in choline-deficient rats.
Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Choline; Choline Deficiency; Growth Hormone | 1956 |
[Therapeutic activity of choline theophyllinate associated with papaverine trichlorohydroxyethyl-p-aminobenzoate].
Topics: Cardiovascular Diseases; Choline; Humans; Papaverine; para-Aminobenzoates; Theophylline | 1958 |
Triparanol and the coloproctologist.
Topics: Cardiovascular Diseases; Choline; Colorectal Surgery; Humans; Postoperative Care; Triparanol | 1961 |
Clinical experience with parenteral heparin-lipotropic therapy in cardiovascular disease; a preliminary report.
Topics: Cardiovascular Diseases; Choline; Heparin; Humans; Lipotropic Agents | 1955 |
Cardiovascular disease in choline-deficient rats. Effects of choline deficiency, nature and level of dietary lipids and proteins, and duration of feeding on plasma and liver lipid values and cardiovascular lesions.
Topics: Animals; Cardiovascular Diseases; Choline; Choline Deficiency; Dietary Fats; Lipids; Liver; Protein | 1962 |
Chemical knockout of C-reactive protein in cardiovascular disease.
Topics: Animals; C-Reactive Protein; Cardiovascular Diseases; Choline; Hexanes; Humans; Molecular Structure; | 2006 |
Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women.
Topics: Aged; Betaine; Cardiovascular Diseases; Choline; Cohort Studies; Diet; Female; Folic Acid; Follow-Up | 2008 |
Feasibility of 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans--first results.
Topics: Angiography; Aorta, Abdominal; Arteries; Calcinosis; Cardiovascular Diseases; Choline; Fluorine Radi | 2008 |
The intraarterial use of acetylcholine in arterial circulatory disorders and especially in ulcers after nerve lesions, frostbite and in scars.
Topics: Cardiovascular Diseases; Choline; Cicatrix; Ulcer | 1949 |
Workshop on Folate, B12, and Choline. Sponsored by the Panel on Folate and other B vitamins of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine, Washington, D.C., March 3-4,
Topics: Biological Availability; Biomarkers; Cardiovascular Diseases; Choline; Congenital Abnormalities; Fem | 1999 |